Your browser doesn't support javascript.
loading
Persistence of Protective Hepatitis B Surface Antibody Titers after Successful Double-Dose Hepatitis B Virus Rescue Vaccination in HIV-Infected Patients
Gut and Liver ; : 86-91, 2012.
Article in English | WPRIM | ID: wpr-196150
ABSTRACT
BACKGROUND/

AIMS:

To assess the durability of protective hepatitis B surface antibody (anti-HBs) titers in HIV-infected patients who responded to double-dose hepatitis B virus (HBV) rescue vaccination.

METHODS:

A retrospective chart review was performed for HIV-infected patients who received the double-dose HBV rescue vaccination at 0-, 1-, and 2-month intervals after they had failed conventional HBV vaccination series. A protective antibody response was defined as an anti-HBs titer > or =10 mIU/mL.

RESULTS:

Of 54 HIV-infected patients who received a double-dose HBV rescue vaccination, 44 patients (81.5%) had a positive response and achieved protective anti-HB titers. Of the 44 patients who developed protective anti-HB titers, 33 patients received an evaluation of their anti-HB titers 12 months later. Of the 33 patients, 19 (57.6%) had persistent protective anti-HB titers (persistent responders, PR), and 14 patients (42.4%) lost their protective anti-HB titers (nonpersistent responders, NPR). There were significantly more patients who had an undetectable HIV viral load (<50 copies/mL) at baseline and follow-up in the PR group (11/19, 57.9%) than in the NPR group (3/14, 21.4%, p=0.036). Logistic regression analysis showed that an undetectable HIV viral load at baseline and follow-up (odds ratio, 12.973; 95% confidence interval, 1.189 to 141.515; p=0.036) was associated with PR.

CONCLUSIONS:

Protective anti-HB titers may decrease over time after successful double-dose HBV rescue vaccination in HIV-infected patients. HIV viral load suppression could improve the persistence of anti-HB titers.
Subject(s)

Full text: Available Index: WPRIM (Western Pacific) Main subject: Logistic Models / Hepatitis B virus / Retrospective Studies / Follow-Up Studies / HIV / Vaccination / Viral Load / Hepatitis / Hepatitis B / Antibody Formation Type of study: Observational study / Prognostic study / Risk factors Limits: Humans Language: English Journal: Gut and Liver Year: 2012 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: WPRIM (Western Pacific) Main subject: Logistic Models / Hepatitis B virus / Retrospective Studies / Follow-Up Studies / HIV / Vaccination / Viral Load / Hepatitis / Hepatitis B / Antibody Formation Type of study: Observational study / Prognostic study / Risk factors Limits: Humans Language: English Journal: Gut and Liver Year: 2012 Type: Article